Agios Pharmaceuticals, Inc. (AGIO) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -118.92M | -96.21M | -88.15M | -77.12M | -111.49M | -133.17M | -84.22M | -72.59M | -99.87M | -72.49M | -61.64M | -66.75M |
| Operating CF Margin % | -573.22% | -481.86% | -684.4% | -619.22% | -1277.66% | -1241.07% | -939.51% | -842.59% | -1219.53% | -1020.53% | -833.13% | -994.46% |
| Operating CF Growth % | -6.67% | 27.75% | -4.67% | -6.25% | -11.64% | -83.71% | -36.62% | -8.75% | -4.92% | -9.56% | 13.61% | 10.08% |
| Net Income | -99.11M | -108.04M | -103.43M | -112.02M | -89.29M | -96.52M | 947.91M | -96.12M | -81.55M | -95.94M | -91.32M | -83.81M |
| Depreciation & Amortization | 1.36M | 1.27M | 1.37M | 1.26M | 1.28M | 1.37M | 1.34M | 1.59M | 1.35M | 1.4M | 1.62M | 4.46M |
| Stock-Based Compensation | 15.54M | 14.12M | 12.38M | 14.69M | 11.36M | 10.9M | 11.14M | 11.56M | 9.23M | 13.81M | 9.08M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -23.59M | 0 | 0 |
| Other Non-Cash Items | 2.09M | 1.03M | 1.76M | 10.66M | 1.67M | -2.65M | -1.09B | 246K | 85K | 26.22M | 21.68M | 8.77M |
| Working Capital Changes | -38.8M | -4.59M | -231K | 8.28M | -36.51M | -46.26M | 45.35M | 10.13M | -28.98M | 5.6M | -2.7M | 3.82M |
| Change in Receivables | -5.55M | -5.55M | -43K | -1.64M | 765K | -991K | 644K | -309K | -643K | -1.63M | 1.07M | -473K |
| Change in Inventory | -2.17M | -886K | -1.19M | -1.24M | -1.99M | -1.19M | -2.49M | -867K | -3.99M | -1.8M | -1.6M | -4.3M |
| Change in Payables | -4.99M | -1.15M | 1.81M | 3.9M | -2.82M | -756K | 7.09M | -1.16M | 1.43M | -3.53M | 1.64M | 2.96M |
| Cash from Investing | 141.31M | 90.08M | 95.56M | 78.97M | 112.59M | -49.16M | 250.79M | 37.24M | 124.56M | 95.51M | 39.34M | 47.13M |
| Capital Expenditures | -769K | -1.12M | -1.55M | -875K | -766K | -967K | -419K | -158K | -141K | -234K | -369K | 3K |
| CapEx % of Revenue | 3.71% | 5.61% | 12.07% | 7.03% | 8.78% | 9.01% | 4.67% | 1.83% | 1.72% | 3.29% | 4.99% | 0.04% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | -40K | 0 | 40K | 0 | 1.18M | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | -10M | 0 | 0 | 1.09B | 0 | 0 | 0 | -17.5M | 0 |
| Cash from Financing | 2.08M | 2.56M | 4.43M | 65K | 1.62M | 4.84M | 2.64M | 1.1M | 5.86M | 847K | 1.88M | 237K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 2.08M | 2.56M | 4.43M | 65K | 1.62M | 4.84M | 2.64M | 1.1M | 5.86M | 847K | 1.88M | 237K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 24.47M | -3.58M | 11.84M | 1.91M | 2.72M | -177.48M | 169.21M | -34.25M | 30.56M | 23.87M | -20.42M | -19.39M |
| Free Cash Flow | -119.69M | -97.33M | -89.71M | -78M | -112.25M | -134.13M | -84.64M | -72.75M | -100.01M | -72.72M | -62.01M | -66.75M |
| FCF Margin % | -576.93% | -487.47% | -696.48% | -626.25% | -1286.44% | -1250.08% | -944.19% | -844.42% | -1221.25% | -1023.82% | -838.11% | -994.41% |
| FCF Growth % | -6.62% | 27.44% | -5.99% | -7.22% | -12.25% | -84.45% | -36.48% | -8.99% | -4.63% | -9.73% | 13.14% | 12.36% |
| FCF per Share | -2.04 | -1.67 | -1.54 | -1.35 | -1.95 | -2.35 | -1.45 | -1.28 | -1.77 | -1.30 | -1.11 | -1.20 |
| FCF Conversion (FCF/Net Income) | 1.20x | 0.89x | 0.85x | 0.69x | 1.25x | 1.38x | -0.09x | 0.76x | 1.22x | 0.76x | 0.67x | 0.80x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 4K | -940K | 65K | 0 | 0 | -525K | 0 | 0 | 525K | -17K | 0 | 0 |